-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, J9Emqsa+oBvswfmHTqOsMZjcjYoT+/f7nGyy//0egke0kVt2LzsOeZpGIdF9jdpS jhTZAPOP/C85sLW/3jCagQ== 0001193125-10-179450.txt : 20100805 0001193125-10-179450.hdr.sgml : 20100805 20100805163934 ACCESSION NUMBER: 0001193125-10-179450 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20100805 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20100805 DATE AS OF CHANGE: 20100805 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ACCELLENT INC CENTRAL INDEX KEY: 0001342505 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 333-130470 FILM NUMBER: 10994987 BUSINESS ADDRESS: STREET 1: 200 WEST 7TH AVE CITY: COLLEGEVILL STATE: PA ZIP: 19426 BUSINESS PHONE: 866-899-1392 MAIL ADDRESS: STREET 1: 200 WEST 7TH AVE CITY: COLLEGEVILL STATE: PA ZIP: 19426 8-K 1 d8k.htm FORM 8-K Form 8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 5, 2010

 

 

ACCELLENT INC.

(Exact name of registrant as specified in its charter)

 

 

 

Maryland   333-130470   84-1507827

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification Number)

100 Fordham Road

Wilmington, Massachusetts

  01887
(Address of principal executive offices)   (Zip Code)

(978) 570-6900

(Registrant’s telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 2.02 Results of Operations and Financial Condition.

On August 5, 2010, Accellent Inc. (the “Company”) issued a press release announcing the Company’s financial results for the quarter ended June 30, 2010. The press release is furnished as Exhibit 99.1 to this current report and is incorporated by reference in this Item 2.02.

As provided in General Instruction B.2 of Form 8-K, the information and exhibits contained in this Form 8-K shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall they be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such a filing.

 

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

 

Exhibit
No.

  

Description

99.1    Press release, dated August 5, 2010, announcing financial results for the quarter ended June 30, 2010 (this exhibit is furnished and not filed)


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: August 5, 2010   ACCELLENT INC.
  By:  

/s/    JEREMY A. FRIEDMAN        

 

Name:

Title:

 

Jeremy A. Friedman

Chief Financial Officer


EXHIBIT INDEX

 

Exhibit
No.

  

Description

99.1    Press release, dated August 5, 2010, announcing financial results for the quarter ended June 30, 2010 (this exhibit is furnished and not filed)
EX-99.1 2 dex991.htm PRESS RELEASE Press Release

Exhibit 99.1

Investor Contact: Jeremy Friedman

Executive Vice President and Chief Financial Officer

978 570 6900

Jeremy.friedman@accellent.com

FOR IMMEDIATE RELEASE

Accellent Inc. Announces Second Quarter 2010 Results

Wilmington, MA (August 5, 2010) – Accellent Inc. (the “Company”), a wholly owned subsidiary of Accellent Holdings Corp. (“Accellent”), today announced results for its fiscal second quarter ended June 30, 2010.

“Second quarter revenue increased 2.6% compared to last year, while adjusted EBITDA reached a near record level. As I work through my third month with Accellent, I am encouraged by these results which reflect on going progress in our selling efforts and improvements in end market economic conditions,” said Donald Spence, President and CEO of Accellent.

Second Quarter 2010 Financial Results

Net sales increased 2.6% to $127.1 million in the second quarter of 2010 compared with $123.9 million in the second quarter of 2009. Income from operations was $18.8 million in the second quarter of 2010, compared to $16.4 million in the second quarter of 2009. Net income was $1.8 million in the second quarter of 2010, compared with a net loss of $1.2 million in the second quarter of 2009.

Adjusted EBITDA for the second quarter of 2010 was $28.9 million, or 22.7% of net sales, compared to Adjusted EBITDA of $29.1 million, or 23.5% of net sales, in the second quarter of 2009.

Six Months Ended June 30, 2010 Financial Results

Net sales were $249.8 million in the first six months of 2010, compared with $250.3 million in the first six months of 2009. Income from operations was $33.4 million in the first six months of 2010 compared with $31.8 million in the first six months of 2009. Net loss was $6.0 million in the first six months of 2010 compared with a net loss of $0.6 million in the first six months of 2009. Our net loss in the first six months of 2010 includes $6.0 million of costs associated with the refinancing of the company’s term loan in January 2010.

Adjusted EBITDA for the first six months of 2010 was $53.6 million or 21.5% of net sales compared to adjusted EBITDA of $55.9 million, or 22.3% of net sales, in the first six months of 2009.

Reconciliations of non-GAAP financial measures to GAAP financial measures are provided in the financial information accompanying this press release.


Conference Call

Donald Spence, President and Chief Executive Officer and Jeremy Friedman, Executive Vice President and Chief Financial Officer will discuss second quarter 2010 results in a conference call scheduled for today, August 5, 2010 at 5:00 p.m. Eastern Time. The teleconference can be accessed live on the Internet through the Investor Relations section of the Accellent website at www.accellent.com or by calling (800) 901-5231, pass code 37697398. Please dial in or visit the website 10 to 15 minutes prior to the beginning of the call to download and install any necessary audio software. A replay of the conference call will be available via www.accellent.com or by telephone at (888) 286-8010 pass code 90699178 beginning August 5, 2010 at 6:00 p.m. through September 12, 2010.

About Accellent

Accellent provides fully integrated outsourced manufacturing and engineering services to the medical device industry in the cardiology, endoscopy and orthopaedic markets. Accellent has broad capabilities in design and engineering services, precision component fabrication, finished device assembly and complete supply chain management solutions. These capabilities enhance our customers’ speed to market and their return on investment by allowing them to focus their internal resources more efficiently. For more information, please visit www.accellent.com.

Forward-Looking Statements

This press release includes “forward looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Act of 1934, as amended. All statements included herein, other than statements of historical fact, may constitute forward-looking statements. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, it can give no assurance that such expectations will prove to be correct. Important factors that could cause actual results to differ materially from the Company’s expectations are disclosed in the risk factors contained in the Company’s Annual Report on Form 10-K for the year ended December 31, 2009 filed with the Securities and Exchange Commission on March 31, 2010. All forward-looking statements are expressly qualified in their entirety by such risk factors.


Accellent Inc.

Condensed Consolidated Statements of Operations

(in thousands)

(unaudited)

 

     Three Months Ended     Six Months Ended  
     June 30,
2009
    June 30,
2010
    June 30,
2009
    June 30,
2010
 

Net sales

   $ 123,909      $ 127,097      $ 250,258      $ 249,777   

Cost of sales (exclusive of amortization)

     88,997        89,769        180,461        180,175   
                                

Gross profit

     34,912        37,328        69,797        69,602   

Operating expenses:

        

Selling, general and administrative expenses

     12,581        14,101        26,296        27,352   

Research and development expenses

     697        678        1,377        1,356   

Restructuring charges

     1,145        —          2,481        —     

Amortization of intangible assets

     3,735        3,735        7,470        7,470   

Loss (gain) on disposal of property and equipment

     315        (13     355        (13
                                

Total operating expenses

     18,473        18,501        37,979        36,165   
                                

Income from operations

     16,439        18,827        31,818        33,437   

Interest expense, net

     (14,281     (18,859     (29,284     (36,283

Loss on debt extinguishment

     —          (215     —          (6,005

Other (expense) income, net

     (2,067     3,229        (1,111     5,495   
                                

Income (loss) before income taxes

     91        2,982        1,423        (3,356

Provision for income taxes

     1,323        1,193        2,046        2,674   
                                

Net (loss) income

   $ (1,232   $ 1,789      $ (623   $ (6,030
                                


Accellent Inc.

Reconciliation of Net (Loss) Income to EBITDA to Adjusted EBITDA

(in thousands)

(unaudited)

 

     Three Months Ended     Six Months Ended  
     June 30,
2009
    June 30,
2010
    June 30,
2009
    June 30,
2010
 

Net (loss) income

   $ (1,232   $ 1,789      $ (623   $ (6,030

Interest expense, net

     14,281        18,859        29,284        36,283   

Provision for income taxes

     1,323        1,193        2,046        2,674   

Depreciation and amortization

     9,253        9,283        18,356        18,629   
                                

EBITDA (1)

     23,625        31,124        49,063        51,556   

Restructuring charges

     1,145        —          2,481        —     

Stock-based compensation – employees

     516        229        604        244   

Stock-based compensation - non-employees

     18        23        48        45   

Employee severance and relocation

     235        209        667        515   

Currency translation loss (gain)

     1,671        (1,848     567        (3,149

Change in fair value of derivative instruments

     408        (1,377     593        (2,286

Loss (gain) on disposal of property and equipment

     315        (13     355        (13

Other taxes

     —          43        —          85   

Plant closure costs

     899        1        899        20   

Loss on debt extinguishment

     —          215        —          6,005   

Management fees to stockholder

     289        304        579        608   
                                

Adjusted EBITDA (1)

   $ 29,121      $ 28,910      $ 55,856      $ 53,630   
                                


Accellent Inc.

Condensed Consolidated Balance Sheets

(In thousands)

(unaudited)

 

     December 31, 2009    June 30, 2010

Assets

     

Current assets:

     

Cash and cash equivalents

   $ 33,785    $ 34,220

Accounts receivable, net

     44,815      54,215

Inventory

     55,571      64,338

Prepaid expenses and other current assets

     4,008      3,828
             

Total current assets

     138,179      156,601

Property, plant and equipment, net

     117,976      116,537

Goodwill

     629,854      629,854

Intangible assets, net

     179,566      172,096

Deferred financing costs and other assets, net

     13,400      17,255
             

Total assets

   $ 1,078,975    $ 1,092,343
             

Liabilities and Stockholder’s equity

     

Current liabilities:

     

Current portion of long-term debt

   $ 7    $ 6

Accounts payable

     23,910      24,631

Accrued expenses and other current liabilities

     31,749      47,731
             

Total current liabilities

     55,666      72,368

Long-term debt

     684,650      690,842

Other long-term liabilities

     32,143      32,474
             

Total liabilities

     772,459      795,684

Stockholder’s equity

     306,516      296,659
             

Total liabilities and stockholder’s equity

   $ 1,078,975    $ 1,092,343
             


(1) EBITDA and Adjusted EBITDA presented in this press release are supplemental measures of our performance that are not required by, or presented in accordance with, GAAP. EBITDA and Adjusted EBITDA are not measurements of our financial performance under GAAP and should not be considered as alternatives to net (loss) income or any other performance measures derived in accordance with GAAP, or as an alternative to cash flow from operating activities as a measure of our liquidity.

EBITDA represents net (loss) income before net interest expense, provision for income taxes, depreciation and amortization. Adjusted EBITDA represents EBITDA further adjusted to give effect to unusual and/or non-cash items, including adjustments for restructuring charges and related plant closure costs, changes in the fair value of derivative instruments, gains and losses resulting from the disposal of property and equipment, currency translation gains and losses, stock compensation charges, severance and relocation costs, certain taxes, loss on debt extinguishment, and management fees.

We believe that the presentation of EBITDA and Adjusted EBITDA is appropriate to provide additional information to investors. We consider it an important supplemental measure of our performance and we believe that both are frequently used by securities analysts, investors and other interested parties in the evaluation of high yield issuers.

-----END PRIVACY-ENHANCED MESSAGE-----